Regeneron quarterly profit surges on COVID-19 antibody cocktail demand By Reuters
© Reuters. (Reuters) – Regeneron Pharmaceuticals Inc (NASDAQ:) reported a more than tripling of its quarterly profit on Thursday, buoyed by robust demand for its COVID-19 antibody cocktail. The antibody therapy, REGEN-COV, has been authorized […]
